Immunohistochemical study of STAT3 expression in feline injection-site fibrosarcomas

Journal of Comparative Pathology

Volumn 134, Issue 1, 2006, Pages 91-100

  Petterino, C ^a   Martano, M ^b   Cascio, P ^b   Cerruti, F ^b   Martini, M ^a   Morello, E ^b   Bruno, R ^b   Castagnaro, M ^a   Buracco, Paolo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cat; Doxorubicin; Injection site fibrosarcoma; STAT3; Tumour

Indexed keywords

DOXORUBICIN; STAT3 PROTEIN; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CARCINOGENESIS; CAT; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MITOSIS; NONHUMAN; PREOPERATIVE CARE; PROTEIN EXPRESSION; SCORING SYSTEM; WESTERN BLOTTING; ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; DRUG EFFECT; GENETICS; GIANT CELL; IMMUNOLOGY; METABOLISM; METHODOLOGY; NECROSIS; PATHOLOGY; REPRODUCIBILITY;

ANIMALIA; FELIDAE;

ANIMALS; BLOTTING, WESTERN; CATS; CELL DIFFERENTIATION; CELL DIVISION; DOXORUBICIN; FIBROSARCOMA; GIANT CELLS; IMMUNOHISTOCHEMISTRY; NECROSIS; REPRODUCIBILITY OF RESULTS; STAT3 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 30844470193     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2005.07.005     Document Type: Article

References (43)

1. S. Alas B. Bonavida Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs Cancer Research 61 2003 5137-5144
2. Y. Aoki G.M. Feldman G. Tosato Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma Blood 101 2003 1535-1542
3. G. Berclaz H.J. Altermatt V. Rohrbach A. Siragusa E. Dreher P.D. Smith EGFR dependent expression of STAT3 (but not STAT1) in breast cancer International Journal of Oncology 19 2001 1155-1160
4. T. Bowman M.A. Broome D. Sinibaldi W. Wharton W.J. Pledger J.M. Sedivy R. Irby T. Yeatman S.A. Courtneidge R. Jove Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis Proceedings of the National Academy of Sciences of the USA 98 2001 7319-7324
5. X. Cao A. Tay G.R. Guy Y.H. Tan Activation and association of Stat3 with Src in v-Src-transformed cell lines Molecular Cell Biology 16 1996 1595-1603
6. S.K. Chai G.L. Nichols P. Rothman Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients Journal of Immunology 159 1997 4720-4728
7. S.S. Couto S.M. Griffey P.C. Duarte B.R. Madewell Feline vaccine-associated fibrosarcoma: Morphologic distinctions Veterinary Pathology 39 2002 33-41
8. R. Dhir Z. Ni W. Lou F. DeMiguel J.R. Grandis A.C. Gao Stat3 activation in prostatic carcinomas Prostate 51 2002 241-246
9. R. Fahrig J.C. Heinrich B. Nickel F. Wilfert C. Leisser G. Krupitza C. Praha D. Sonntag B. Fiedler H. Scherthan H. Ernst Inhibition of induced chemoresistance by cotreatmen with (E)-5-(2-bromovinyl)-2′-deoxyuridine (RP101) Cancer Research 63 2003 5745-5753
10. A. Fernandes A.W. Hamburger B.I. Gerwin ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells International Journal of Cancer 83 1999 564-570
11. T. Fukada T. Ohtani Y. Yoshida T. Shirogane K. Nishida K. Nakajima M. Hibi T. Hirano STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell cycle transition EMBO Journal 17 1998 6670-6677
12. R. Garcia C. Yu A. Hudnall R. Catlett K. Nelson T. Sminthgall D.J. Fujita S. Ethier R. Jove Constitutive activation of STAT3 in fibroblast transformed by diverse oncoproteins and in breast cancer cells Cell Growth & Differentiation 8 1997 1267-1276
13. M.J. Hendrick Feline vaccine-associated sarcomas: Current studies on pathogenesis Journal of the American Veterinary Medical Association 213 1998 1425-1426
14. Hendrick, M.J., Mahaffey, E.A., Moore, F.M., Vos, J.H. and Walder, E.J. (1998). Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animals, Second Series, Vol. II, Armed Forces Institute of Pathology, Washington DC.
15. A. Horiguchi M. Oya T. Shimada A. Uchida K. Marumo M. Murai Activation of signal transducer and activator of transcription 3 in renal cell carcinomas: A study of incidence and its association with pathological features and clinical outcome Journal of Urology 168 2002 762-765
16. J.J. Jacoby A. Kalinowski M.G. Liu S.S.M. Zhang Q. Gao G.X. Chai L. Ji Y. Iwamoto E. Li M. Schneider K.S. Russell X.Y. Fu Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proceedings of the National Academy of Sciences of the USA 100 2003 12929-12934
17. A. Joo H. Aburatani E. Morii H. Iba A. Yoshimura I.T.F. STAT3 STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression Oncogene 23 2004 726-734
18. K. Kunisada S. Negoro E. Tone M. Funamoto T. Osugi S. Yamada M. Okabe T. Kishimoto K. Yamauchi-Takihara Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy Proceedings of the National Academy of Sciences of the USA 97 2000 315-319
19. R. Lai G.Z. Rassidakis L.J. Medeiros V. Leventaki M. Keating T.J. McDonnell Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours Journal of Pathology 199 2003 84-89
20. V. Lee A.K. Randhawa P.K. Singal Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals American Journal of Physiology 261 1991 H989-H995
21. M. Martano E. Morello M. Ughetto S. Iussich C. Petterino P. Cascio P. Buracco Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: A report on 69 cases Veterinary Journal 170 2005 84-90
22. L.B. Mora R. Buettner J. Seigne J. Diaz N. Ahmad R. Garcia T. Bowman R. Falcone R. Fairclough A. Cantor C. Muro-Cacho S. Livingston J. Karras J. Pow-Sang R. Jove Constitutive activation of Stat3 in human prostate tumours and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells Cancer Research 62 2002 6659-6666
23. C.E. Myers W.P. McGuire R.H. Liss I. Ifrim K. Grotzinger R.C. Young Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response Science 197 1977 165-167
24. G. Niu T. Bowman M. Huang S. Shivers D. Reintgen A. Daud A. Chang A. Kraker R. Jove H. Yu Roles of activated Src and Stat3 signaling in melanoma tumour cell growth Oncogene 21 2002 7001-7010
25. E.J. Noronha K.H. Sterling K.L. Calame Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus Journal of Biological Chemistry 278 2003 50915-50922
26. C. Petterino M. Martini M. Castagnaro STAT3 expression in canine mammary gland tumours and mammary gland hyperplasia European Journal of Veterinary Pathology 7 2001 117-122
27. B.E. Powers P.J. Hoppes E.J. Ehrhart Tumor diagnosis, grading and staging Seminars in Veterinary Medicine and Surgery (Small Animal) 10 1995 158-167
28. S.O. Rahaman P.C. Harbor O. Chernova G.H. Barnett M.A. Vogelbaum S.J. Haque Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells Oncogene 21 2002 8404-8413
29. P.J. Real A. Sierra A. De Juan J.C. Segovia J.M. Lopez-Vega J.L. Fernandez-Luna Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 21 2002 7611-7618
30. A. Rebbaa P.M. Chou B.L. Mirkin Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis Molecular Medicine 7 2001 393-400
31. E.J. Schlette L.J. Medeiros A. Goy R. Lai G.Z. Rassidakis Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma Journal of Clinical Oncology 22 2004 1682-1688
32. A. Scholz S. Heinze K.M. Detjen M. Peters M. Welzel P. Hauff M. Schirner B. Wiedenmann S. Rosewicz Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer Gastroenterology 125 2003 891-905
33. D. Sinibaldi W. Wharton J. Turkson T. Bowman W.J. Pledger R. Jove Induction of p21WAF1/CIP1 and cyclin D1 expression by Src oncoprotein in mouse fibroblasts: Role of activated STAT3 signaling Oncogene 19 2000 5419-5427
34. J.I. Song J.R. Grandis STAT signaling in head and neck cancer Oncogene 19 2000 2489-2495
35. M. Thomas E. Finnegan K.M.A. Rogers J.W. Purcell A. Trimble P.G. Johnston M.P. Boland STAT1. A modulator of chemotherapy-induced apoptosis. Cancer Research 64 2004 8357-8364
36. T. Toyonaga K. Nakamo M. Nagano G. Zhao K. Yamaguchi S. Kuroki T. Eguchi K. Chijiiwa M. Tsuneyoshi M. Tanaka Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhbits growth of human pancreatic cancer Cancer Letters 201 2003 107-116
37. T. Wang G. Niu M. Kortylewski L. Burdelya K. Shain S. Zhang R. Bhattacharya D. Gabrilovich R. Heller D. Coppola W. Dalton R. Jove D. Pardoll H. Yu Regulation of the innate and adaptative immune responses by Stat-3 signaling in tumour cells Nature Medicine 10 2003 48-54
38. C.J. Watson W.R. Miller Elevated levels of members of STAT family of transcription factors in breast carcinoma nuclear extracts British Journal of Cancer 71 1995 840-844
39. R.M. Weber-Nordt C. Egen J. Wehinger W. Ludwig V. Gouilleux-Gruart R. Mertelsmann J. Finke Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and Epstein-Barr virus (EBV)-related lymphoma cell lines Blood 88 1996 809-816
40. T.X. Xie D. Wei M. Liu A.C. Gao F. Ali-Osman R. Sawaya S. Huang Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumour invasion and metastasis. Oncogene 23 2004 3550-3560
41. T. Yoshida T. Hanada T. Tokuhisa K. Kosai M. Sata M. Kohara A. Yoshimura Activation of STAT3 by hepatitis C virus core protein leads to cellular transformation Journal of Experimental Medicine 196 2002 641-653
42. Yu, C. L., Meyer, D. J., Campbell, G. S., Lamer, A. C., Carter-Su, C., Schwartz, J. and Jove, R. (1995). Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by Src oncoprotein. Science, 269, 81-83.
43. A. Zamo R. Chiarle R. Piva J. Howes Y. Fan M. Chiosi D.E. Levy G. Inghirami Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death Oncogene 21 2002 1038-1047